Antitumour properties of dimethylsulphoxide ruthenium(II) complexes in the Lewis lung carcinoma system
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 21 (5) , 617-628
- https://doi.org/10.1016/1043-6618(89)90204-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cis- and trans-dihalotetrakis(dimethyl sulfoxide)ruthenium(II) complexes (RuX2(DMSO)4; X = Cl, Br): synthesis, structure, and antitumor activityInorganic Chemistry, 1988
- Synthesis, antitumor activity, and x-ray structure of bis(imidazolium) (imidazole)pentachlororuthenate(III), (ImH)2(RuImCl5)Inorganic Chemistry, 1987
- Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III)Zeitschrift für Krebsforschung und Klinische Onkologie, 1986
- Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasmsEuropean Journal of Cancer and Clinical Oncology, 1984
- Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lewis lung carcinomaChemico-Biological Interactions, 1983
- ANTITUMOR ACTION OF 2 RHODIUM AND RUTHENIUM COMPLEXES IN COMPARISON WITH CIS-DIAMMINEDICHLOROPLATINUM(II)1977
- The induction of filamentous growth in Escherichia coli by ruthenium and palladium complexesChemico-Biological Interactions, 1976
- Transition metal complexes in cancer chemotherapyCoordination Chemistry Reviews, 1974
- Biological Activity of Complex IonsNature, 1952
- A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS1949